MINI FUTURE LONG - VIRBAC Share Price

Certificat

HS3IB

FRBNPP04UNB2

Market Closed - Euronext Paris 17:30:01 13/05/2024 BST
1.45 EUR +1.40% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+8.21%
1 month-5.23%
Date Price Change Volume
13/05/24 1.45 +1.40% 21
10/05/24 1.43 0.00% 12
09/05/24 1.43 0.00% 13
08/05/24 1.43 +5.93% 23
07/05/24 1.35 -4.26% 19

Real-time Euronext Paris

Last update May 13, 2024 at 05:30 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIRBAC
IssuerLogo Issuer BNP Paribas BNP Paribas
HS3IB
ISINFRBNPP04UNB2
Date issued 27/09/2022
Strike 217.1
Maturity Unlimited
Parity 100 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.635
Lowest since issue 0.255
Spread 0.06
Spread %4.05%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
357 EUR
Average target price
368 EUR
Spread / Average Target
+3.08%
Consensus
  1. Stock Market
  2. Certificates
  3. HS3IB Certificat